The role of CCDC125 in neuroblastoma remains uncharacterised, but its upregulation is a good prognostic biomarker for gastric and thyroid cancers, which contrasts to our prediction in neuroblastoma [24,71], suggesting possible tissue-specificity. Here, CCDC125 is linked to neuroblastoma.